Cite
APA Citation
Veenstra, V., Damhofer, H., Waasdorp, C., Rijssen, L., Vijver, M., Dijk, F., Wilmink, H., Besselink, M., Busch, O., Chang, D., Bailey, P., Biankin, A., Kocher, H., Medema, J., Li, J., Jiang, R., Pierce, D., Laarhoven, H., & Bijlsma, M. (n.d.). aDAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy. Oncogenesis, 7, 1–11. http://access.bl.uk/ark:/81055/vdc_100086850527.0x000135